文献速递肿瘤 PET/CT放射性药物与辐射防护

重症患者PET/CT应用实践与障碍的国际调查

Practices and barriers in PET/CT use for critically ill patients: an international survey.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-09-12

该研究通过欧洲重症医学会(ESICM)与欧洲核医学协会(EANM)在全球发放电子问卷,调查重症监护病房(ICU)患者[18F]-FDG-PET/CT的使用现状与障碍。

要点

  • ICU患者[18F]-FDG-PET/CT使用频率低,43%的用户每年仅做1-5例。
  • 主要适应证为感染(74%)、恶性肿瘤(57%)和不明原因发热(49%)。
  • 缺乏标准化协议与流程障碍突出,亟待ESICM与EANM共识指南。

核心结论

  • 国际调查显示ICU患者[18F]-FDG-PET/CT使用差异大且存在明显实践障碍,亟需共识指南与流程优化。

主要发现

  • 63%的受访者来自大学医院,71%专于ICU、29%专于核医学影像;78%的中心有核医学科,但仅60%与ICU同址。
  • 使用频率低:43%的用户每年做1-5例,四分之一每月做1-2例。
  • 主要适应证为感染(74%)、恶性肿瘤(57%)、不明原因发热(49%);放射性药物给药主要在核医学科(77%),仅50%的机构有特定饮食准备方案。

关键数值与推荐

  • 感染作为首要诊断技术使用占74%,恶性肿瘤57%,不明原因发热49%;核医学科给药占77%,特定饮食准备方案存在于50%的机构。

临床怎么用

  • 调查结果将用于ESICM与EANM后续联合建议,推动标准化协议与简化流程以优化ICU患者的诊断价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 2-deoxy-2-[18F] fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography ([18F]-FDG-PET/CT) offers high diagnostic sensitivity for occult infection, malignancy and inflammatory processes - conditions that frequently complicate critical‑care patients. Despite this potential, routine use of [18F]-FDG-PET/CT in the intensive care unit (ICU) remains sporadic and there are no formal guidelines to direct its application. The objective of the study is to describe current international practice, identify barriers to implementation, and provide a data‑driven foundation for future consensus recommendations on [18F]-FDG-PET/CT use in ICU patients. METHODS: An electronic questionnaire was disseminated worldwide through the European Society of Intensive Care Medicine (ESICM) and the European Association of Nuclear Medicine (EANM). The survey collected demographic information, hospital characteristics, availability and location of nuclear‑medicine services, clinical indications for [18F]-FDG-PET/CT in critically ill patients, frequency of use, workflow organization, and perceived obstacles. Forty‑one respondents from 16 countries completed the survey. RESULTS: Most participants worked in university hospitals (63%) and specialised either in ICU care (71%) or nuclear imaging (29%). A nuclear‑medicine department (NMD) was available in 78% of centres, but only 60% were co‑located with the ICU. [18F]-FDG-PET/CT was performed infrequently: 43% of users performed 1-5 scans per year and a fourth performed 1-2 scans per month. The use of PET/CT as primary diagnostic technique was infection (74%), followed by malignancy (57%) and fever of unknown origin (49%). Radiotracer administration occurred mainly in the NMD (77%) and specific dietary preparation protocols were present in only 50% of sites. Reported barriers included lack of standardised protocols, prolonged procedure duration, limited imaging slots, ambiguous indications, insufficient staff expertise, and logistical difficulties transporting unstable ICU patients. CONCLUSION: This international survey reveals marked heterogeneity in [18F]-FDG-PET/CT utilisation and significant practical obstacles in the ICU setting. The data highlight an unmet need for consensus guidelines and streamlined workflows to optimise the diagnostic value of [18F]-FDG-PET/CT in critical‑care patients. Findings will inform forthcoming joint recommendations by ESICM and EANM, ultimately aiming to enhance patient outcomes through evidence‑based imaging protocols.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Genovese C, Timsit JF, Thy M, et al. Practices and barriers in PET/CT use for critically ill patients: an international survey. Eur J Nucl Med Mol Imaging. 2026. PMID: 42730762. doi:10.1007/s00259-026-08172-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。